Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.
Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.
复制标题
DOI:
10.1038/s41588-021-00838-7
复制
发表时间:
2021-06
期刊:
影响因子:
30.8
通讯作者:
Pellman D
中科院分区:
文献类型:
--
作者:
Leibowitz ML;Papathanasiou S;Doerfler PA;Blaine LJ;Sun L;Yao Y;Zhang CZ;Weiss MJ;Pellman D
Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using model cells and single-cell whole genome sequencing, as well as by editing at a clinically relevant locus in clinically relevant cells, we show that CRISPR-Cas9 editing generates structural defects of the nucleus—micronuclei and chromosome bridges—that initiate a mutational process called chromothripsis. Chromothripsis is extensive chromosome rearrangement restricted to one or a few chromosomes that can cause human congenital disease and cancer. These results demonstrate that chromothripsis is a previously unappreciated on-target consequence of CRISPR-Cas9-generated DSBs. As genome editing is implemented in the clinic, the potential for extensive chromosomal rearrangements should be considered and monitored.
登录
查看更多内容
影响因子:
64.5
作者:
Hsu PD;Lander ES;Zhang F
通讯作者:
Zhang F
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
16
作者:
Canela A;Sridharan S;Sciascia N;Tubbs A;Meltzer P;Sleckman BP;Nussenzweig A
通讯作者:
Nussenzweig A
影响因子:
64.8
作者:
Dever DP;Bak RO;Reinisch A;Camarena J;Washington G;Nicolas CE;Pavel-Dinu M;Saxena N;Wilkens AB;Mantri S;Uchida N;Hendel A;Narla A;Majeti R;Weinberg KI;Porteus MH
通讯作者:
Porteus MH
影响因子:
30.8
作者:
Enache, Oana M.;Rendo, Veronica;Ben-David, Uri
通讯作者:
Ben-David, Uri